NewAmsterdam Pharma Company N.V. Ordinary Shares NAMS
$22.58
-0.70%
at last close
Financials (TTM)
- Revenue
- $7.12 million
- Net Income
- $-259,504,000
- Net Margin
- -3644.21%
- Return on Equity
- -41.10%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 4.27
- Price / Sales
- 379.04
Over the trailing twelve months, NewAmsterdam Pharma Company N.V. Ordinary Shares generated revenue of $7.12 million and net income of $-259,504,000, a net margin of -3644.21%.
At the last closing price of $22.58, NAMS trades at 379.04 times sales, with a market capitalization of $2.70 billion.
Key Stats
- Last Close
- $22.58
- Market Cap
- $2.70 billion
- 52-Week Range
- $21.02 – $42.20
- Average Volume
- 1.52 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.